Evicenter
Vyndamax (tafamidis) in Transthyretin amyloid cardiomyopathy
Manufacturer
Pfizer Inc
Questions
71
Last updated

All questions

Safety: Vyndamax (tafamidis) in transthyretin amyloid cardiomyopathy

9 questions · 3 sources

Side effects

What are the side effects of Vyndamax?

Note: The label's adverse event data come from ATTR-CM trials of VYNDAQEL (tafamidis meglumine), as the first passage states. The second passage is from the FDA-approved Patient Information printed with the label.

Vyndamax ATTR-ACT trial: how often did Vyndaqel patients stop for side effects?

What are the long-term side effects of Vyndamax (ATTR-ACT extension)?

Note: These passages describe a post hoc, interim analysis of the ATTR-ACT long-term extension, in which patients received VYNDAQEL and then transitioned to VYNDAMAX.

Warnings

What are the contraindications for Vyndamax?

Safety

Did Vyndamax (tafamidis) cause cancer in animal studies?

Does Vyndamax (tafamidis) affect fertility?

Note: This finding is from rat studies of tafamidis meglumine in the Nonclinical Toxicology section of the label.

Does Vyndamax prolong the QT interval?

Monitoring

Does Vyndamax affect thyroid function tests?

Does Vyndamax require lab monitoring?

Note: The dosing page of the Vyndamax HCP site cites the 2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis for this statement.